GlobeImmune is developing Tarmogen product candidates to treat cancer and infectious diseases.
|
Tarmogens® - Targeted Molecular Immunotherapy® Tarmogens activate the immune system by stimulating cellular immunity, known as T cell immunity, in contrast to traditional vaccines, which predominately stimulate antibody production. Tarmogens target the molecular profile that distinguishes a diseased cell from a normal cell, and are designed to target specific antigens that play a role in oncology indications and infectious diseases. READ MORE » 
|
Fact SheetLearn about our Tarmogen® platform, our leading oncology and infectious disease product candidates and our GlobeImmune management team. 
|
Recent News
|
||